Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET

MALIGNANT TUMORS of the head and neck region are often potentially curable by locoregional treatment if they are diagnosed at an early stage.1 Therefore, the early detection and accurate differentiation between malignant and benign mass lesions is important when such differentiation is difficult clinically for planning appropriate therapy. For this purpose, in many instances, the conventional imaging techniques such as computed tomography (CT), Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET

[1]  Tsuneo Suzuki,et al.  Uptake rates of 18F-fluorodeoxyglucose and 11C-choline in lung cancer and pulmonary tuberculosis: a positron emission tomography study. , 2003, Chest.

[2]  E. Yoshikawa,et al.  Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  S. Tanada,et al.  11C-choline PET for the detection of bone and soft tissue tumours in comparison with FDG PET , 2003, Nuclear medicine communications.

[4]  G. Hutchins,et al.  [11C]Choline as a potential PET marker for imaging of breast cancer athymic mice. , 2002, Nuclear medicine and biology.

[5]  S. Berlangieri,et al.  Evaluation of 18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography With Histopathologic Correlation in the Initial Staging of Head and Neck Cancer , 2002 .

[6]  H. Groen,et al.  Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  R. Coleman,et al.  Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  T. Shiga,et al.  Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  A. Scott.  Current status of positron emission tomography in oncology , 2001, Internal medicine journal.

[10]  Sven N. Reske,et al.  Experience with carbon-11 choline positron emission tomography in prostate carcinoma , 2000, European Journal of Nuclear Medicine.

[11]  H. Minn,et al.  Blood metabolism of [methyl-11C]choline; implications for in vivo imaging with positron emission tomography , 2000, European Journal of Nuclear Medicine.

[12]  N. Kosaka,et al.  Positron emission tomography of esophageal carcinoma using (11)C-choline and (18)F-fluorodeoxyglucose: a novel method of preoperative lymph node staging. , 1999, Cancer.

[13]  T. Hara,et al.  Automated synthesis of [11C]choline, a positron-emitting tracer for tumor imaging. , 1999, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[14]  Susan M. Chang,et al.  Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. , 1997, Journal of neurosurgery.

[15]  N. Shinoura,et al.  PET imaging of brain tumor with [methyl-11C]choline. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  R. Wahl,et al.  Effect of hyperglycemia on in vitro tumor uptake of tritiated FDG, thymidine, L-methionine and L-leucine. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  S. Yasuda,et al.  High fluorine-18 labeled deoxyglucose uptake in sarcoidosis. , 1996, Clinical nuclear medicine.

[18]  R. Wahl,et al.  Influence of hypoxia on tracer accumulation in squamous-cell carcinoma: in vitro evaluation for PET imaging. , 1996, Nuclear medicine and biology.

[19]  H. Degani,et al.  Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method. , 1996, Anticancer research.

[20]  D J Jenden,et al.  In vivo 1H MRS choline: correlation with in vitro chemistry/histology. , 1996, Life sciences.

[21]  J L Roodenburg,et al.  Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  W. Panje,et al.  How I do it: Head and neck and plastic surgery: Surgical management of the head and neck cancer patient following concomitant multimodality therapy , 1995 .

[23]  K. Greven,et al.  Salivary gland tumors: pretherapy evaluation with PET. , 1994, Radiology.

[24]  A. Harris,et al.  Phosphomonoester is associated with proliferation in human breast cancer: a 31P MRS study. , 1993, British Journal of Cancer.

[25]  T Ido,et al.  Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  E Abemayor,et al.  Positron emission tomography: A new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy , 1992, The Laryngoscope.

[27]  K. Någren,et al.  Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  K. Hamacher,et al.  Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  A. Wolf,et al.  Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  P. Wedeking,et al.  Distribution and metabolism of intravenously administered choline[methyl- 3-H] and synthesis in vivo of acetylcholine in various tissues of guinea pigs. , 1975, The Journal of pharmacology and experimental therapeutics.

[31]  T. Higuchi,et al.  A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer. , 2003, Nuclear medicine communications.

[32]  B. Nowak,et al.  Diagnostic Evaluation of Malignant Head and Neck Cancer by F-18-FDG PET Compared to CT/MRI , 1999, Nuklearmedizin.

[33]  W N Hanafee,et al.  Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation. , 1993, Radiology.

[34]  S. Zeisel.  Dietary choline: biochemistry, physiology, and pharmacology. , 1981, Annual review of nutrition.